Inventor · disambiguated record
Shinji Kagaya
Also filed as: KAGAYA SHINJI
6 granted patents·7 pending applications·29 citations·filing 2002–2024
76Inventor score
Files withS&K BIOPHARMA INC3JAPAN AS REPRESENTED BY GENERA2NRL PHARMA INC2HOSHINO TATSUO1KAGAYA SHINJI1
Top patents by PatentIndex Score
13 records- 0180US7115373B2Method of testing for atopic dermatitis by measuring expression of the NOR-1 geneJAPAN AS REPRESENTED BY GENERA·Filed 2003·Granted Oct 3, 2006·24 cites·4 claims
- 0276US9809641B2Lactoferrin fusion protein and method for preparation thereofNRL PHARMA INC·Filed 2013·Granted Nov 7, 2017·3 cites·6 claims
- 0373US2025025537A1Glycosaminoglycan inhibitor and promoterS&K BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0472US11041014B2Lactoferrin/albumin fusion protein and production method thereforS & K BIOPHARMA INC·Filed 2017·Granted Jun 22, 2021·1 cites·17 claims
- 0561US2022031813A1Inhibitor of extracellular trap formation in leukocytesKAGAYA SHINJI·Filed 2021·Application pending·0 cites
- 0658US7172867B2Methods of testing for allergic diseases, and therapeutic agents for treating sameJAPAN AS REPRESENTED BY GENERA·Filed 2003·Granted Feb 6, 2007·1 cites·2 claims
- 0755US2021169991A1Glycosaminoglycan inhibitor and promoterS&K BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 0852US10562959B2Lactoferrin fusion protein and method for preparation thereofNRL PHARMA INC·Filed 2017·Granted Feb 18, 2020·0 cites·13 claims
- 0950US2016067315A1Inhibitor of extracellular trap formation in leukocytesUNIV TOKYO·Filed 2014·Application pending·0 cites
- 1046US11298358B2Combination therapy using ascochlorin derivativeHOSHINO TATSUO·Filed 2018·Granted Apr 12, 2022·0 cites·13 claims
- 1140US2017296629A1Inhibitor of extracellular trap formation in leukocyteKAWAKAMI HIROSHI·Filed 2015·Application pending·0 cites
- 1228US2004197786A1Method of examining steroid resnponsivenessFiled 2002·Application pending·0 cites
- 1323US2004234969A1Mehtod for examining steroid-responsivenessFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →